SEARCH

SEARCH BY CITATION

References

  • Bodendorf U., Danner S., Fischer F., Stefani M., Sturchler-Pierrat C., Wiederhold K., Staufenbiel M. and Paganetti P. (2002) Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid. J. Neurochem. 80, 799806.
  • Cai H., Wang Y., Mccarthy D., Wen H., Borchelt D., Price D. and Wong P. (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat. Neurosci. 4, 233234.
  • Citron M., Vigo-Pelfrey C., Teplow D., Miller C., Schenk D., Johnston J., Winblad B., Venizelos N., Lannfelt L. and Selkoe D. (1994) Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl Acad. Sci. USA 91, 11 99311 997.
  • Haass C., Lemere C., Capell A., Citron M., Seubert P., Schenk D., Lannfelt L. and Selkoe D. (1995) The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nat. Med. 1, 12911296.
  • Hong H., Hwang E., Sim H., Cho H., Boo J., Oh S., Kim S. and Mook-Jung I. (2003) Interferon gamma stimulates beta-secretase expression and sAPPbeta production in astrocytes. Biochem. Biophys. Res. Commun. 307, 922927.
  • Hong L., Koelsch G., Lin X., Wu S., Terzyan S., Ghosh A., Zhang X. and Tang J. (2000) Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science 290, 150153.
  • Hussain I., Powell D., Howlett D. et al. (1999) Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 14, 419427.
  • Hussain I., Powell D., Howlett D. et al. (2000) ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site. Mol. Cell. Neurosci. 16, 609619.
  • Lin X., Koelsch G., Wu S., Downs D., Dashti A. and Tang J. (2000) Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc. Natl Acad. Sci. USA 97, 14561460.
  • Liu K., Doms R. and Lee V. (2002) Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression. Biochemistry 41, 31283136.
  • Luo Y., Bolon B., Kahn S. et al. (2001) Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat. Neurosci. 4, 231232.
  • Marcinkeviciene J., Luo Y., Graciani N., Combs A. and Copeland R. (2001) Mechanism of inhibition of beta-site amyloid precursor protein-cleaving enzyme (BACE) by a statine-based peptide. J. Biol. Chem. 276, 23 79023 794.
  • Naslund J., Schierhorn A., Hellman U. et al. (1994) Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc. Natl Acad. Sci. USA 91, 83788382.
  • Pastorino L., Ikin A., Nairn A., Pursnani A. and Buxbaum J. (2002) The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total A (beta). Mol. Cell. Neurosci. 19, 175185.
  • Pype S., Moechars D., Dillen L. and Mercken M. (2003) Characterization of amyloid beta peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein. J. Neurochem. 84, 602609.
  • Roberds S., Anderson J., Basi G. et al. (2001) BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum. Mol. Genet. 10, 13171324.
  • Rossor M., Newman S., Frackowiak R., Lantos P. and Kennedy A. (1993) Alzheimer's disease families with amyloid precursor protein mutations. Ann. NY Acad. Sci. 695, 198202.
  • Selkoe D. (1996) Amyloid beta-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271, 18 29518 298.
  • Sinha S., Anderson J., Barbour R. et al. (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537540.
  • Tamaoka A., Odaka A., Ishibashi Y. et al. (1994) APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1–42/43 and a beta 1–40) in familial Alzheimer's disease brain. J. Biol. Chem. 269, 32 72132 724.
  • Turner R. R., Loy J., Nguyen C., Devasamudram T., Ghosh A., Koelsch G. and Tang J. (2002) Specificity of memapsin 1 and its implications on the design of memapsin 2 (beta-secretase) inhibitor selectivity. Biochemistry 41, 87428746.
  • Vassar R., Bennett B., Babu-Khan S. et al. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735741.
  • Walter J., Fluhrer R., Hartung B., Willem M., Kaether C., Capell A., Lammich S., Multhaup G. and Haass C. (2001) Phosphorylation regulates intracellular trafficking of beta-secretase. J. Biol. Chem. 2761, 14 63414 634.
  • Wise A., Foord S., Fraser N. et al. (2003) Molecular identification of high and low affinity receptors for nicotinic acid. J. Biol. Chem. 278, 98699874.
  • Yan R., Bienkowski M., Shuck M. et al. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533537.
  • Yan R., Han P., Miao H., Greengard P. and Xu H. (2001) The transmembrane domain of the Alzheimer's beta-secretase (BACE1) determines its late Golgi localization and access to beta-amyloid precursor protein (APP) substrate. J. Biol. Chem. 276, 36 78836 796.